The largest database of trusted experimental protocols

High binding 384 well elisa plates

Manufactured by Corning
Sourced in United States

High-binding 384-well ELISA plates are designed for enzyme-linked immunosorbent assays (ELISA) that require high protein-binding capacity. The plates feature a 384-well format and are made from high-quality materials to provide a consistent and reliable surface for binding proteins and other biomolecules.

Automatically generated - may contain errors

2 protocols using high binding 384 well elisa plates

1

ELISA for Recombinant Protein Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
High-binding 384-well ELISA plates (Corning, MA) were coated overnight at 4°C with 50 µl/well of recombinant protein diluted in carbonate buffer. The next day, plates were washed with 0.1% Tween-20 in PBS and 200 µl of blocking buffer (PBS+ 1% BSA) added to each well for 2 h at room temperature. After blocking, plates are washed five times before serum samples diluted in 0.1% Tween-20+ 0.1% BSA in PBS was added at 50 µl/well and incubated for 30 min at room temperature. After incubation, plates were washed and 50 µl/well of peroxidase labeled-anti-human IgG (Life Technologies CA) in serum diluent was added. Plates were incubated for 30 min at room temperature, and then washed as previously described. To reveal reactions 100 µl of TMB SureBlue Peroxidase Substrate (Kirkegaard and Perry Laboratories, Gaithersburg, MD) was added to each well for 15 min at room temperature, after which the reaction was stopped by adding 1 N H2SO4. Plates were read within 10 min of reaction stoppage at optical density (OD) 450 nm, using 570 nm as the reference wavelength on a SpectraMax plate reader (Molecular Devices, CA).
+ Open protocol
+ Expand
2

ELISA Protocol for Antibody Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
High-binding 384-well ELISA plates (Corning, Tewksbury, MA, USA) were coated with recombinant protein, and then serial dilutions of the plasma samples and positive control and a single dilution of negative control were prepared in serum diluent. After incubation, peroxidase-labeled anti-human IgG, IgG1, IgG2, IgG3, IgG4 and IgE (Life Technologies, Carlsbad, CA, USA) in serum diluent was added. End-point titer was determined by Graph Prism Nonlinear regression (curve fit) sigmoidal dose response (variable slope) to interpolate unknowns from the last optical density value greater than a threshold determined by sera from normal human plasma pool.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!